• Video
  • Shop
  • Culture
  • Family
  • Wellness
  • Food
  • Living
  • Style
  • Travel
  • News
  • Book Club
  • Newsletter
  • Privacy Policy
  • Your US State Privacy Rights
  • Children's Online Privacy Policy
  • Interest-Based Ads
  • Terms of Use
  • Do Not Sell My Info
  • Contact Us
  • © 2026 ABC News
  • Wellness

GLP-1 weight loss drugs may be misused by patients with eating disorders: Study

9:23
Weight loss wonder drug GLP-1 could be game-changing in addiction treatment
Patrick Bay Damsted/Adobe Stock
ByDr. Samantha Aquino Calpo
June 24, 2026, 9:10 PM

A new study is raising concerns about GLP-1 weight loss drugs and eating disorders.

Researchers found that 32% of patients with eating disorders report having used a weight loss injection at least once, according to a study in JAMA Psychiatry released on Wednesday.

This is more than double the 15% of the general population that uses a GLP-1.

Related Articles

Doctor debunks 'nature's Ozempic' gelatin trend going viral on social media

Experts worry the drugs are being used as a tool to restrict eating or control weight in ways that can make eating disorders worse. This is dangerous because people with eating disorders are already at risk for nutritional deficiencies and disordered relationships with food.  

Over 10% of study participants with eating disorders misused the GLP-1.

Misuse included taking more or less than a prescribed dose, using for a longer period than prescribed, tampering with injection equipment, and sharing with other people, like family and friends, without a prescription. 

GLP-1s can be “incredibly beneficial in the right patient and potentially problematic in the wrong patient,” according to Dr. Stephanie Widmer, a board-certified physician in emergency medicine, toxicology, and addiction medicine. 

Wegovy 1.7 mg injection pens.
Patrick Bay Damsted/Adobe Stock

“Eating disorder screening may need to become as routine as reviewing a patient’s medical history. Identifying active or past eating disorders could help clinicians determine who needs closer follow-up,” Dr. Widmer also told ABC News.  

GLP-1s are primarily for treating type 2 diabetes, obesity, cardiovascular disease, and sleep apnea. They help the pancreas increase the production of insulin to move sugar from the bloodstream into cells and slow the movement of food through the gut, decreasing blood sugar levels and curbing appetite.   

Using GLP-1s for any eating disorders, including anorexia, bulimia or binge eating disorder, is not medically recommended.  

Related Articles

New analysis of GLP-1 drugs suggests people who stopped using medications regained 60% of weight lost

Researchers emphasize the urgent need for vigilance among prescribers, especially as access to GLP-1s expands. 

Board-certified psychiatrist and therapist Dr. Sarah Oreck explained that the key takeaway from this study is that “rapid weight loss can make it harder to recognize when an eating disorder is re-emerging, precisely because the changes are so often socially reinforced.” 

Recovery and asking for help can be challenging -- seek out support groups and reach out to trusted professionals and friends or family.  

Dr. Samantha Aquino Calpo is a third-year family medicine resident physician at Cooper University Health Care and is a member of the ABC News Medical Unit. 

Up Next in Wellness—

Hourly movement breaks can help counter effects of prolonged sitting, study finds

June 24, 2026

Doctor debunks 'nature's Ozempic' gelatin trend going viral on social media

June 24, 2026

Muni Long opens up about lupus battle, lung transplant and recovery

June 23, 2026

Antidepressant recalled due to presence of potentially cancer-causing impurity

June 16, 2026

Shop GMA Favorites

ABC will receive a commission for purchases made through these links.

Sponsored Content by Taboola

The latest lifestyle and entertainment news and inspiration for how to live your best life - all from Good Morning America.
  • Contests
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Info
  • Children’s Online Privacy Policy
  • Advertise with us
  • Your US State Privacy Rights
  • Interest-Based Ads
  • About Nielsen Measurement
  • Press
  • Feedback
  • Shop FAQs
  • ABC News
  • ABC
  • All Videos
  • All Topics
  • Sitemap

© 2026 ABC News
  • Privacy Policy— 
  • Your US State Privacy Rights— 
  • Children's Online Privacy Policy— 
  • Interest-Based Ads— 
  • Terms of Use— 
  • Do Not Sell My Info— 
  • Contact Us— 

© 2026 ABC News